北里大学OPAC

ようこそ  ゲスト さん

Therapy for ocular angiogenesis : principles and practice / [edited by] Arup Das, Thomas Friberg

データ種別 図書
出版者 Philadelphia : Wolters Kluwer Health/Lippincott Williams & Wilkins
出版年 c2011
著者標目 Das, Arup
Friberg, Thomas

所蔵情報を非表示

配架場所 巻 次 請求記号 登録番号 状 態 コメント ISBN 刷 年 予約 利用注記
IPE 図書
WW140||D229t||2011 41048922
9781605476407

書誌詳細を非表示

大きさ p. ; cm
件 名 LCSH:Eye -- Blood-vessels -- Diseases -- Chemotherapy
LCSH:Neovascularization
MESH:Eye Diseases -- drug therapy
MESH:Angiogenesis Inhibitors -- therapeutic use
MESH:Eye -- blood supply
MESH:Neovascularization, Pathologic -- drug therapy
MESH:Neovascularization, Pathologic -- physiopathology
一般注記 Includes bibliographical references and index
Summary: "Ocular angiogenesis, or the abnormal growth of blood vessels in the eye, is the cause of major neovascular eye diseases. In addition, retinal and choroidal neovascularization are the major causes of vision loss in this country. With the new era of anti-angiogenic therapies already in practice, ophthalmologists have started treating many ocular diseases including macular degeneration, diabetic retinopathy, and retinal vascular occlusion using anti-angiogenic drugs. This book covers the basic pathophysiology of ocular angiogenesis and strategies for inhibition. The authors discuss the "Principles" of anti-angiogenic therapy, pre-clinical studies, future drugs on the horizon, drug delivery, and the "Practice" of the therapy in many ocular diseases. Vision researchers in both academia and industry, as well as clinician scientists, have contributed chapters on different aspects of the angiogenic process, and clinical strategies to fight it. The book also includes chapters that deal with diabetic macular
分 類 LCC:RE720
NLM:WW 140
DC22:616.99/484
書誌ID BB10100001
本文言語 英語
巻冊次 : alk. paper ; ISBN:9781605476407
NCID GB56239792

検索結果一覧に戻る ページトップ